EXPAC COMMERCIAL LIMITED
Company number 12954430 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
1. Financial Health Score: B+
Explanation: EXPAC COMMERCIAL LIMITED exhibits a robust pulse in terms of profitability, having injected over half a million pounds into its reserves in the latest year. However, its circulatory system—specifically cash flow—shows signs of temporary constriction. The company is fundamentally healthy but is currently diverting significant resources toward a strategic expansion, resulting in a cash flow discrepancy that requires careful monitoring.
2. Key Vital Signs
- Equity & Reserves (The Heartbeat): £512,172 (up from £100 in 2024). This is a massive, healthy surge. The P&L reserve has absorbed £512,072 in profits, indicating a highly profitable trading year.
- Cash at Bank (Blood Pressure): £40,437 (down from £59,820 in 2024). Despite the massive profit, cash reserves have dropped by roughly a third. This is a classic symptom of cash being tied up elsewhere rather than sitting in the bank.
- Debtors / Prepayments (Arterial Flow): £742,118 (up from £130,693). The most glaring vital sign is the £688,282 sitting in "Prepayments and accrued income" (up from £48,333). This explains where all the cash went—the business paid heavily in advance for something.
- Current Liabilities (Cholesterol Levels): £270,383 (up from £190,413). The increase is manageable and includes a healthy £87,928 Corporation Tax bill, which is a natural side effect of high profitability.
- Operating Leases (Long-term Stamina): Commitments doubled from £150,690 to £310,000, suggesting the company has taken on significantly larger physical premises or equipment leases to support growth.
3. Diagnosis
Symptoms Analysis: The financial data reveals a business undergoing a major growth spurt. The patient is generating exceptional profit, but the circulatory system (cash flow) is currently stressed. The £688,282 in prepayments is an unusual symptom for a company of this size, but the notes to the accounts provide the cure for this mystery.
The Diagnosis: Strategic Expansion On 30th January 2026, the company completed the acquisition of a third-party contract manufacturer and packing company. The massive £688k prepayment is clearly the deposit or advance payment for this acquisition. The business has effectively drained its cash reserves and leveraged its current assets to fund this purchase.
Operating as a subsidiary of GRI Expac Limited, the company has the backing of a larger group structure, which acts as a safety net. The unqualified audit report confirms that despite this heavy capital outlay, the company's financial statements present a true and fair view. The patient is not sick; rather, it is expending immense energy to swallow a large meal (the acquisition), which has temporarily suppressed its immediate cash liquidity.
Prognosis: The outlook is positive, provided the acquisition digests well. The company has proven its ability to generate strong profits organically. If the newly acquired assets integrate smoothly and contribute to revenue, the current cash strain will quickly alleviate. However, the immediate future will be characterized by tight cash flow, and the business will be vulnerable to any unexpected shocks until the acquisition begins paying for itself.
4. Recommendations
- Post-Acquisition Cash Therapy: With cash at bank dropping to £40k while holding over £270k in current liabilities, cash flow management must be the immediate priority. Ensure that the newly acquired business generates swift cash collections to replenish the bank account.
- Monitor the "Digestion" Period: Keep a close eye on the integration of the acquired contract manufacturer. The success of this financial health assessment hinges entirely on the prepayments converting into tangible, revenue-generating assets.
- Group Circulatory Support: Given the tight cash position, maintain clear, open communication with the parent company (GRI Expac Limited) regarding working capital needs. Should the integration take longer than expected, the parent entity may need to act as a financial drip to support day-to-day operations.
- Review Lease Obligations: With operating lease commitments doubling to £310k, ensure that the expanded premises are fully utilized and contributing to the top line, rather than just adding fixed overhead pressure to an already cash-constrained balance sheet.